Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression
Authors:
Open Access
- 4 February 2021
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 40 (1) , 1-15
Abstract
Background: Hepatocellular carcinoma (HCC) is a common type of malignant human cancer with high morbidity and poor prognosis, causing numerous deaths per year worldwide. Growing evidence has been demonstrated that long non-coding RNAs (lncRNAs) are closely associated with hepatocarcinogenesis and metastasis. However, the roles, functions, and working mechanisms of most lncRNAs in HCC remain poorly defined. Methods: Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression level of CCDC183-AS1 in HCC tissues and cell lines. Cell proliferation, migration and invasion ability were evaluated by CCK-8 and transwell assay, respectively. Animal experiments were used to explore the role of CCDC183-AS1 and miR-589-5p in vivo. Bioinformatic analysis, dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to confirm the regulatory relationship between CCDC183-AS1, miR-589-5p and SKP1. Results: Significantly upregulated expression of CCDC183-AS1 was observed in both HCC tissues and cell lines. HCC patients with higher expression of CCDC183-AS1 had a poorer overall survival rate. Functionally, overexpression of CCDC183-AS1 markedly promoted HCC cell proliferation, migration and invasion in vitro and tumor growth and metastasis in vivo, whereas the downregulation of CCDC183-AS1 exerted opposite effects. MiR-589-5p inhibitor counteracted the proliferation, migration and invasion inhibitory effects induced by CCDC183-AS1 silencing. Mechanistically, CCDC183-AS1 acted as a ceRNA through sponging miR-589-5p to offset its inhibitory effect on the target gene SKP1, then promoted the tumorigenesis of HCC. Conclusions: CCDC183-AS1 functions as an oncogene to promote HCC progression through the CCDC183-AS1/miR-589-5p/SKP1 axis. Our study provided a novel potential therapeutic target for HCC patients.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81572855, 81572427)
- The State Key Project on Infectious Diseases of China (2018ZX10723204-003)
- the national key Research and Development Program of China (2018YFA0208904)
- Major Technological Innovation Projects of Hubei Province (2018ACA137)
This publication has 42 references indexed in Scilit:
- Predicting effective microRNA target sites in mammalian mRNAseLife, 2015
- miRWalk2.0: a comprehensive atlas of microRNA-target interactionsNature Methods, 2015
- lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine SignalsCell, 2014
- A Guide for miRNA Target Prediction and Analysis Using Web-Based Applications2014
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflowsNucleic Acids Research, 2013
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular CarcinomaCancer Cell, 2012
- NF‐κB and the link between inflammation and cancerImmunological Reviews, 2012
- Akt‐dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesisThe EMBO Journal, 2012
- Prediction of both conserved and nonconserved microRNA targets in animalsBioinformatics, 2007
- Swimming in cloudy waters: Efforts to prevent HCV-related HCCGastroenterology, 2005